Covid-19 Research

Research Article

Genetic Identification of EBNA1 Gene in Cases of Infectious Mononucleosis (IM) in the Metropolitan Region of Belem, Para, Brazil

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Research Article
Subject Biology Group
OCLC JBRES Record
Monteiro TAF*, Costa IB, Brasil-Costa I, Coelho BMR, Ramos FLP, Monteiro JLF, Sousa Junior EC, Bandeira RS, Gabbay YB and Sousa RC
Issue: Volume5-Issue8
Pages: 912-920
Received: 2024-07-28
Accepted: 2024-08-04
Published: 2024-08-08

Abstract

Background: EBV Nuclear Antigen 1 (EBNA1) is a multifunctional protein of 641 amino acids. In host cells it is essential for the maintenance, replication and transcription of the EBV genome in expressed in both latent and lytic modes of infection. Objetive this study aimed to characterize the EBNA1 gene in cases of Infectious Mononucleosis (IM) in the metropolitan region of Belém/Pará/Brazil, period of 2005-2016.

Methods: The detection of the EBNA1 gene occurred in 26 positive cases of infectious mononucleosis were investigated by the Health Service of the Evandro Chagas Institute, using the Nested PCR and sequencing, these strains were analyzed, edited and compared with the prototype B95-8 (GenBank V01555.2) and MK540312.

Results: Phylogenetic analysis identified two EBNA1 variants, the P-ala with a rate of 23.1% (6/26) and V-Leu in 19.2% (5/26), and the subvariants V-LeuAg in 30.8% (8/26), P-Thr' in 11.5% (3/26), P-ala' in 7.7% (2/26) and V-alaiii in 7.7% (2/26). As for the origin of the sequenced cases, in the Belém strains (76.9% - 20/26) the presence of all types of EBNA1 was verified: P-ala and V-leu in 20% (4/20) each; V-LeuAg in 30.0% (6/20), P-Thr' in 15%, (3/20); P-ala' in 10% (2/20); and V-alaiii in 5% (1/20). Regarding the EBNA1 gene, of the 26 IM strains, six (23.1%) showed identical alignment to the B95-8 prototype sequence, with the others, a total of 17 amino acid alterations were observed.

Conclusion: The genetic identification of EBNA1 in the present study allowed for the first time to distinguish the molecular epidemiology and the circulation of these viral agents, highlighted its characteristic of viral persistence in clinical specimens of lymphocytes identified in IM strains coming from individuals of the northern Brazil.

FullText HTML FullText PDF DOI: 10.37871/jbres1971 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Monteiro TAF, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Monteiro TAF, Costa IB, Brasil-Costa I, Coelho BMR, Ramos FLP, Monteiro JLF, Sousa Junior EC, Bandeira RS, Gabbay YB, Sousa RC. Genetic Identification of EBNA1 Gene in Cases of Infectious Mononucleosis (IM) in the Metropolitan Region of Belem, Para, Brazil. J Biomed Res Environ Sci. 2024 Aug 08; 5(8): 912-920. doi: 10.37871/jbres1971, Article ID: JBRES1971, Available at: https://www.jelsciences.com/articles/jbres1971.pdf

Subject area(s)

GenomicsVirology

References

  1. Varvatsi D, Richter J, Tryfonos C, Pantzaris M, Christodoulou C. Association of Epstein-Barr virus latently expressed genes with multiple sclerosis. Mult Scler Relat Disord. 2021 Jul;52:103008. doi: 10.1016/j.msard.2021.103008. Epub 2021 May 7. PMID: 34010765.
  2. Afrasiabi A, Parnell GP, Swaminathan S, Stewart GJ, Booth DR. The interaction of multiple sclerosis risk loci with epstein-barr virus phenotypes implicates the virus in pathogenesis. Sci Rep. 2020;10(1):193. doi: 10.1038/s41598-019-55850-z.
  3. Wu YK, Jiang TT, Su YH, Mei L, Sun TK, Li YH, Wang ZD, Ji YY. The potential role of virus infection in the progression of thyroid cancer. World J Oncol. 2024;15(3):382-393. doi: 10.14740/wjon1830.
  4. Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):20160270. doi: 10.1098/rstb.2016.0270. PMID: 28893937; PMCID: PMC5597737.
  5. Bairwa R, Malhotra H, Tanwar VS, Soni S, Sai, R. Utility of plasma epstein-barr viral load in managing hodgkin’s lymphoma: A prospective study. Int J Acad Med Pharm. 2024;6(2):727-731.
  6. Monteiro TAF, Arnaud MVC, Barros VLS, Monteiro JLF, Vasconcelos PFC. Identificação do Gene EBER1 e EBNA1 do virus de Epstein Barr (EBV) em tecidos de pacientes com doença de Hodgkin na região Norte do Brasil. Rev Panam Infectol. 2014;16(1):17-24.
  7. Brasil-Costa I, de Souza CRT, Costa IB, Dos Santos LFP, Paixão LCF, Polaro AA, Monteiro TAF, Burbano RMR. Detection of Epstein-Barr virus in gastric adenocarcinoma: qPCR and FISH comparison. Med Microbiol Immunol. 2022 Feb;211(1):29-36. doi: 10.1007/s00430-021-00724-3. Epub 2021 Dec 3. PMID: 34862564; PMCID: PMC8860788.
  8. Vafapour Z, Tabatabaie FH, Hosseini SY, Haghighat S, Hashemi SMA, Moattari A, Sarvari J. Sequence variation of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene in chronic lymphocytic leukemia and healthy volunteer subjects. Arch Virol. 2023 Dec 8;169(1):1. doi: 10.1007/s00705-023-05933-0. PMID: 38063941.
  9. Jácome-Santos H, Amanajás TA, Gomes STM, Machado LFA, Pereira Neto ARL, Alves Junior SM, Pinheiro JJV, Alves BP, Amoras-Alves ACB. Epstein-Barr virus (EBV) in periodontal sites of human immunodeficiency virus (HIV)-positive individuals in North Brazil: a cross-sectional study. Quintessence Int. 2020;51(1):18-26. doi: 10.3290/j.qi.a43616. PMID: 31781689.
  10. Marcucci SB, Obeidat AZ. EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis. J Neuroimmunol. 2020 Feb 15;339:577116. doi: 10.1016/j.jneuroim.2019.577116. Epub 2019 Nov 20. PMID: 31805475.
  11. Frappier L. EBNA1. Curr Top Microbiol Immunol. 2015;391:3-34. doi: 10.1007/978-3-319-22834-1_1. PMID: 26428370.
  12. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984 Jul 19-25;310(5974):207-11. doi: 10.1038/310207a0. PMID: 6087149.
  13. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol. 1991 Mar;65(3):1466-78. doi: 10.1128/JVI.65.3.1466-1478.1991. PMID: 1847464; PMCID: PMC239927.
  14. Shah WA, Ambinder RF, Hayward GS, Hayward SD. Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions. J Virol. 1992 Jun;66(6):3355-62. doi: 10.1128/JVI.66.6.3355-3362.1992. PMID: 1316452; PMCID: PMC241114.
  15. Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene. 1996 Jul 4;13(1):177-81. PMID: 8700544.
  16. Gutiérrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, Tsao SW, Yuen PW, Joab I, Magrath IT, Bhatia K. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol. 1997 Jul;78 ( Pt 7):1663-70. doi: 10.1099/0022-1317-78-7-1663. PMID: 9225043.
  17. Lorenzetti MA, Altcheh J, Moroni S, Moscatelli G, Chabay PA, Preciado MV. EBNA1 sequences in Argentinean pediatric acute and latent Epstein-Barr virus infection reflect circulation of novel South American variants. J Med Virol. 2010 Oct;82(10):1730-8. doi: 10.1002/jmv.21871. PMID: 20827771.
  18. Sanger F, Air GM, Barrell BG, Brown NL, Coulson AR, Fiddes CA, Hutchison CA, Slocombe PM, Smith M. Nucleotide sequence of bacteriophage phi X174 DNA. Nature. 1977 Feb 24;265(5596):687-95. doi: 10.1038/265687a0. PMID: 870828.
  19. Huang X, Madan A. CAP3: A DNA sequence assembly program. Genome Res. 1999 Sep;9(9):868-77. doi: 10.1101/gr.9.9.868. PMID: 10508846; PMCID: PMC310812.
  20. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013 Apr;30(4):772-80. doi: 10.1093/molbev/mst010. Epub 2013 Jan 16. PMID: 23329690; PMCID: PMC3603318.
  21. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond A. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012 Jun 15;28(12):1647-9. doi: 10.1093/bioinformatics/bts199. Epub 2012 Apr 27. PMID: 22543367; PMCID: PMC3371832.
  22. Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015 Jan;32(1):268-74. doi: 10.1093/molbev/msu300. Epub 2014 Nov 3. PMID: 25371430; PMCID: PMC4271533.
  23. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol. 2009 Jul;26(7):1641-50. doi: 10.1093/molbev/msp077. Epub 2009 Apr 17. PMID: 19377059; PMCID: PMC2693737.
  24. Zhang H, Gao S, Lercher MJ, Hu S, Chen WH. EvolView, an online tool for visualizing, annotating and managing phylogenetic trees. Nucleic Acids Res. 2012 Jul;40(Web Server issue):W569-72. doi: 10.1093/nar/gks576. Epub 2012 Jun 13. PMID: 22695796; PMCID: PMC3394307.
  25. Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene. 1996 Jul 4;13(1):177-81. PMID: 8700544.
  26. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 1995 Jun 22;375(6533):685-8. doi: 10.1038/375685a0. PMID: 7540727.
  27. Wilson JB, Manet E, Gruffat H, Busson P, Blondel M, Fahraeus R. EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers. Cancers (Basel). 2018 Apr 6;10(4):109. doi: 10.3390/cancers10040109. PMID: 29642420; PMCID: PMC5923364.
  28. Wang Y, Liu X, Xing X, Cui Y, Zhao C, Luo B. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res. 2010 Feb;147(2):258-64. doi: 10.1016/j.virusres.2009.11.010. Epub 2009 Nov 24. PMID: 19941915.
  29. Sun L, Zhao Z, Liu S, Liu X, Sun Z, Luo B. Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China. PLoS One. 2015 Oct 13;10(10):e0140529. doi: 10.1371/journal.pone.0140529. PMID: 26460969; PMCID: PMC4604123.
  30. Bhatia K, Magrath I. EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma. J Virol. 1999 Aug;73(8):7096-7. PMID: 10465649; PMCID: PMC112804.
  31. Gutiérrez MI, Spangler G, Kingma D, Raffeld M, Guerrero I, Misad O, Jaffe ES, Magrath IT, Bhatia K. Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood. 1998 Jul 15;92(2):600-6. PMID: 9657761.
  32. Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB. Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol. 1999 Feb;73(2):965-75. doi: 10.1128/JVI.73.2.965-975.1999. PMID: 9882297; PMCID: PMC103916.
  33. Sandvej K, Zhou XG, Hamilton-Dutoit S. EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction. J Pathol. 2000 Jun;191(2):127-31. doi: 10.1002/(SICI)1096-9896(200006)191:2<127::AID-PATH614>3.0.CO;2-E. PMID: 10861570.
  34. Zhang XS, Wang HH, Hu LF, Li A, Zhang RH, Mai HQ, Xia JC, Chen LZ, Zeng YX. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett. 2004 Jul 28;211(1):11-8. doi: 10.1016/j.canlet.2004.01.035. PMID: 15194212.
  35. Thuan LD, Kha ND, Minh NT, Thuy L. Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma from Vietnam. Balkan J Med Genet. 2019 Aug 28;22(1):61-68. doi: 10.2478/bjmg-2019-0011. PMID: 31523622; PMCID: PMC6714338.
  36. Ai J, Xie Z, Liu C, Huang Z, Xu J. Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children. Virol J. 2012 Jan 11;9:13. doi: 10.1186/1743-422X-9-13. PMID: 22236445; PMCID: PMC3269356.
  37. Do NV, Ingemar E, Phi PT, Jenny A, Chinh TT, Zeng Y, Hu L. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res. 2008 Mar;132(1-2):15-24. doi: 10.1016/j.virusres.2007.10.020. Epub 2007 Dec 21. PMID: 18096263.
  38. Mai SJ, Ooka T, Li DJ, Zeng MS, Jiang RC, Yu XJ, Zhang RH, Chen SP, Zeng YX. Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line. Oncol Rep. 2007 Jan;17(1):141-6. PMID: 17143491.
  39. Münz C. Humanized mouse models for Epstein Barr virus infection. Curr Opin Virol. 2017 Aug;25:113-118. doi: 10.1016/j.coviro.2017.07.026. Epub 2017 Aug 22. PMID: 28837889.
  40. Zumwalde NA, Sharma A, Xu X, Ma S, Schneider CL, Romero-Masters JC, Hudson AW, Gendron-Fitzpatrick A, Kenney SC, Gumperz JE. Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model. JCI Insight. 2017 Jul 6;2(13):e93179. doi: 10.1172/jci.insight.93179. PMID: 28679955; PMCID: PMC5499361.
  41. Farrell PJ. Epstein-Barr virus. The B95-8 strain map. Methods Mol Biol. 2001;174:3-12. doi: 10.1385/1-59259-227-9:3. PMID: 11357658.
  42. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol. 1991 Mar;65(3):1466-78. doi: 10.1128/JVI.65.3.1466-1478.1991. PMID: 1847464; PMCID: PMC239927.
  43. Bell MJ, Brennan R, Miles JJ, Moss DJ, Burrows JM, Burrows SR. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. J Infect Dis. 2008 Jun 1;197(11):1594-7. doi: 10.1086/587848. PMID: 18419576.
  44. Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, Kermode AG, Nolan D. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. PLoS One. 2016 Feb 5;11(2):e0147567. doi: 10.1371/journal.pone.0147567. PMID: 26849221; PMCID: PMC4744032.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership